Enzo Biochem, Inc. (ENZ)
USD 0.36
(-4.98%)
USD 0.36
(-4.98%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -52.1 Million USD | 35.17% |
| 2023 | -75.37 Million USD | -7318.8% |
| 2022 | -1.01 Million USD | -111.1% |
| 2021 | 9.15 Million USD | 160.71% |
| 2020 | -15.07 Million USD | 72.86% |
| 2019 | -55.54 Million USD | 6.94% |
| 2018 | -59.68 Million USD | 6.14% |
| 2017 | -63.59 Million USD | 2.64% |
| 2016 | -65.32 Million USD | -349.78% |
| 2015 | -14.52 Million USD | -8.88% |
| 2014 | -13.33 Million USD | -187.6% |
| 2013 | -4.63 Million USD | 69.24% |
| 2012 | -15.07 Million USD | -6.46% |
| 2011 | -14.16 Million USD | -61.67% |
| 2010 | -8.75 Million USD | -26.41% |
| 2009 | -6.92 Million USD | 91.15% |
| 2008 | -78.32 Million USD | 25.51% |
| 2007 | -105.14 Million USD | -50.53% |
| 2006 | -69.85 Million USD | 9.02% |
| 2005 | -76.78 Million USD | -41.66% |
| 2004 | -54.19 Million USD | 14.33% |
| 2003 | -63.26 Million USD | 5.76% |
| 2002 | -67.13 Million USD | -14.43% |
| 2001 | -58.67 Million USD | -14.98% |
| 2000 | -51.02 Million USD | -18.12% |
| 1999 | -43.2 Million USD | -28.96% |
| 1998 | -33.5 Million USD | -32.94% |
| 1997 | -25.2 Million USD | -43.18% |
| 1996 | -17.6 Million USD | -179.37% |
| 1995 | -6.3 Million USD | -373.91% |
| 1994 | 2.3 Million USD | -57.41% |
| 1993 | 5.4 Million USD | 1.89% |
| 1992 | 5.3 Million USD | -85.32% |
| 1991 | 36.1 Million USD | -6.96% |
| 1990 | 38.8 Million USD | 97.96% |
| 1989 | 19.6 Million USD | 335.56% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -58.06 Million USD | 6.62% |
| 2024 Q1 | -62.17 Million USD | 17.51% |
| 2024 Q4 | -52.1 Million USD | 10.99% |
| 2024 Q3 | -54.89 Million USD | 5.45% |
| 2023 Q1 | 7.35 Million USD | 824.11% |
| 2023 Q2 | 13.55 Million USD | 84.23% |
| 2023 Q4 | -75.37 Million USD | -490.81% |
| 2023 FY | -75.37 Million USD | -7318.8% |
| 2023 Q3 | 19.28 Million USD | 42.3% |
| 2022 Q2 | 16.65 Million USD | 8.44% |
| 2022 Q4 | -1.01 Million USD | 90.65% |
| 2022 FY | -1.01 Million USD | -111.1% |
| 2022 Q1 | 15.36 Million USD | 67.83% |
| 2022 Q3 | -10.86 Million USD | -165.22% |
| 2021 Q1 | -14.24 Million USD | 5.51% |
| 2021 Q4 | 9.15 Million USD | 163.93% |
| 2021 Q2 | -13.65 Million USD | 4.16% |
| 2021 Q3 | -14.31 Million USD | -4.86% |
| 2021 FY | 9.15 Million USD | 160.71% |
| 2020 Q2 | -24.3 Million USD | 14.69% |
| 2020 Q3 | -28 Million USD | -15.22% |
| 2020 Q1 | -28.48 Million USD | 48.72% |
| 2020 Q4 | -15.07 Million USD | 46.16% |
| 2020 FY | -15.07 Million USD | 72.86% |
| 2019 Q4 | -55.54 Million USD | 7.15% |
| 2019 Q1 | -52.45 Million USD | 12.11% |
| 2019 FY | -55.54 Million USD | 6.94% |
| 2019 Q3 | -59.81 Million USD | -59.45% |
| 2019 Q2 | -37.51 Million USD | 28.49% |
| 2018 Q3 | -62.15 Million USD | 2.85% |
| 2018 FY | -59.68 Million USD | 6.14% |
| 2018 Q1 | -66.31 Million USD | -4.28% |
| 2018 Q2 | -63.97 Million USD | 3.53% |
| 2018 Q4 | -59.68 Million USD | 3.96% |
| 2017 Q1 | -64.41 Million USD | 1.39% |
| 2017 Q2 | -61.72 Million USD | 4.16% |
| 2017 Q3 | -61.97 Million USD | -0.39% |
| 2017 FY | -63.59 Million USD | 2.64% |
| 2017 Q4 | -63.59 Million USD | -2.62% |
| 2016 Q4 | -65.32 Million USD | -126.9% |
| 2016 Q3 | -28.78 Million USD | 10.9% |
| 2016 Q2 | -32.31 Million USD | -19.32% |
| 2016 FY | -65.32 Million USD | -349.78% |
| 2016 Q1 | -27.07 Million USD | -86.46% |
| 2015 Q1 | -12.55 Million USD | 5.89% |
| 2015 Q4 | -14.52 Million USD | -41.19% |
| 2015 Q2 | -11.23 Million USD | 10.53% |
| 2015 FY | -14.52 Million USD | -8.88% |
| 2015 Q3 | -10.28 Million USD | 8.41% |
| 2014 Q1 | -2.65 Million USD | 42.71% |
| 2014 FY | -13.33 Million USD | -187.6% |
| 2014 Q2 | -3.62 Million USD | -36.58% |
| 2014 Q3 | -10.72 Million USD | -195.4% |
| 2014 Q4 | -13.33 Million USD | -24.43% |
| 2013 Q3 | -4.52 Million USD | 49.56% |
| 2013 Q4 | -4.63 Million USD | -2.43% |
| 2013 FY | -4.63 Million USD | 69.24% |
| 2013 Q1 | -12.6 Million USD | 16.42% |
| 2013 Q2 | -8.97 Million USD | 28.76% |
| 2012 FY | -15.07 Million USD | -6.46% |
| 2012 Q2 | -8.58 Million USD | 24.51% |
| 2012 Q4 | -15.07 Million USD | -187.33% |
| 2012 Q3 | -5.24 Million USD | 38.91% |
| 2012 Q1 | -11.37 Million USD | 19.66% |
| 2011 Q4 | -14.16 Million USD | -45.85% |
| 2011 Q1 | -8.75 Million USD | 0.08% |
| 2011 Q2 | -8.98 Million USD | -2.71% |
| 2011 Q3 | -9.7 Million USD | -8.01% |
| 2011 FY | -14.16 Million USD | -61.67% |
| 2010 Q2 | -8.15 Million USD | -34.29% |
| 2010 FY | -8.75 Million USD | -26.41% |
| 2010 Q4 | -8.75 Million USD | -1.88% |
| 2010 Q1 | -6.07 Million USD | 12.34% |
| 2010 Q3 | -8.59 Million USD | -5.39% |
| 2009 Q1 | -36.82 Million USD | 52.98% |
| 2009 FY | -6.92 Million USD | 91.15% |
| 2009 Q2 | -8.48 Million USD | 76.97% |
| 2009 Q3 | -7.55 Million USD | 10.92% |
| 2009 Q4 | -6.92 Million USD | 8.27% |
| 2008 FY | -78.32 Million USD | 25.51% |
| 2008 Q1 | -103.78 Million USD | 1.3% |
| 2008 Q2 | -98.55 Million USD | 5.04% |
| 2008 Q3 | -96.5 Million USD | 2.08% |
| 2008 Q4 | -78.32 Million USD | 18.84% |
| 2007 Q4 | -105.14 Million USD | 12.39% |
| 2007 FY | -105.14 Million USD | -50.53% |
| 2007 Q1 | -71.96 Million USD | -3.01% |
| 2007 Q2 | -110.91 Million USD | -54.14% |
| 2007 Q3 | -120.02 Million USD | -8.21% |
| 2006 Q1 | -75.04 Million USD | 2.26% |
| 2006 FY | -69.85 Million USD | 9.02% |
| 2006 Q4 | -69.85 Million USD | 7.8% |
| 2006 Q3 | -75.76 Million USD | 0.53% |
| 2006 Q2 | -76.16 Million USD | -1.49% |
| 2005 Q4 | -76.78 Million USD | -4.62% |
| 2005 Q1 | -68.31 Million USD | -26.05% |
| 2005 FY | -76.78 Million USD | -41.66% |
| 2005 Q3 | -73.39 Million USD | -6.64% |
| 2005 Q2 | -68.82 Million USD | -0.74% |
| 2004 FY | -54.19 Million USD | 14.33% |
| 2004 Q4 | -54.19 Million USD | 9.49% |
| 2004 Q1 | -63.44 Million USD | -0.28% |
| 2004 Q3 | -59.87 Million USD | -0.12% |
| 2004 Q2 | -59.8 Million USD | 5.74% |
| 2003 FY | -63.26 Million USD | 5.76% |
| 2003 Q1 | -73.24 Million USD | -9.11% |
| 2003 Q3 | -79.11 Million USD | -4.19% |
| 2003 Q2 | -75.93 Million USD | -3.67% |
| 2003 Q4 | -63.26 Million USD | 20.03% |
| 2002 Q2 | -61.88 Million USD | -1.09% |
| 2002 Q1 | -61.21 Million USD | -4.34% |
| 2002 FY | -67.13 Million USD | -14.43% |
| 2002 Q4 | -67.13 Million USD | -5.65% |
| 2002 Q3 | -63.54 Million USD | -2.68% |
| 2001 Q4 | -58.67 Million USD | -3.87% |
| 2001 Q3 | -56.48 Million USD | -3.86% |
| 2001 Q2 | -54.38 Million USD | -1.59% |
| 2001 FY | -58.67 Million USD | -14.98% |
| 2001 Q1 | -53.53 Million USD | -4.92% |
| 2000 Q1 | -44.3 Million USD | -2.55% |
| 2000 Q4 | -51.02 Million USD | -7.06% |
| 2000 Q3 | -47.66 Million USD | -2.49% |
| 2000 Q2 | -46.5 Million USD | -4.97% |
| 2000 FY | -51.02 Million USD | -18.12% |
| 1999 FY | -43.2 Million USD | -28.96% |
| 1999 Q3 | -41.9 Million USD | -4.23% |
| 1999 Q2 | -40.2 Million USD | -2.55% |
| 1999 Q1 | -39.2 Million USD | -17.01% |
| 1999 Q4 | -43.2 Million USD | -3.1% |
| 1998 Q3 | -32 Million USD | -3.23% |
| 1998 Q2 | -31 Million USD | -3.68% |
| 1998 FY | -33.5 Million USD | -32.94% |
| 1998 Q4 | -33.5 Million USD | -4.69% |
| 1998 Q1 | -29.9 Million USD | -18.65% |
| 1997 Q3 | -23.5 Million USD | -2.17% |
| 1997 Q1 | -23.3 Million USD | -32.39% |
| 1997 FY | -25.2 Million USD | -43.18% |
| 1997 Q4 | -25.2 Million USD | -7.23% |
| 1997 Q2 | -23 Million USD | 1.29% |
| 1996 FY | -17.6 Million USD | -179.37% |
| 1996 Q1 | -10.7 Million USD | -69.84% |
| 1996 Q3 | -11.2 Million USD | 2.61% |
| 1996 Q4 | -17.6 Million USD | -57.14% |
| 1996 Q2 | -11.5 Million USD | -7.48% |
| 1995 Q3 | -7.2 Million USD | 6.49% |
| 1995 Q1 | -10.9 Million USD | -573.91% |
| 1995 Q2 | -7.7 Million USD | 29.36% |
| 1995 FY | -6.3 Million USD | -373.91% |
| 1995 Q4 | -6.3 Million USD | 12.5% |
| 1994 Q2 | -300 Thousand USD | 82.35% |
| 1994 Q1 | -1.7 Million USD | -131.48% |
| 1994 FY | 2.3 Million USD | -57.41% |
| 1994 Q4 | 2.3 Million USD | 53.33% |
| 1994 Q3 | 1.5 Million USD | 600.0% |
| 1993 Q2 | 5.3 Million USD | 1.92% |
| 1993 Q1 | 5.2 Million USD | -1.89% |
| 1993 FY | 5.4 Million USD | 1.89% |
| 1993 Q4 | 5.4 Million USD | 12.5% |
| 1993 Q3 | 4.8 Million USD | -9.43% |
| 1992 Q4 | 5.3 Million USD | -45.92% |
| 1992 Q3 | 9.8 Million USD | 2.08% |
| 1992 Q1 | 37.2 Million USD | 3.05% |
| 1992 FY | 5.3 Million USD | -85.32% |
| 1992 Q2 | 9.6 Million USD | -74.19% |
| 1991 Q1 | 42.1 Million USD | 8.51% |
| 1991 Q3 | 46.4 Million USD | 17.17% |
| 1991 Q4 | 36.1 Million USD | -22.2% |
| 1991 Q2 | 39.6 Million USD | -5.94% |
| 1991 FY | 36.1 Million USD | -6.96% |
| 1990 Q4 | 38.8 Million USD | 39.07% |
| 1990 FY | 38.8 Million USD | 97.96% |
| 1990 Q2 | 24.9 Million USD | 12.67% |
| 1990 Q3 | 27.9 Million USD | 12.05% |
| 1990 Q1 | 22.1 Million USD | 12.76% |
| 1989 FY | 19.6 Million USD | 335.56% |
| 1989 Q4 | 19.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.14 Billion USD | 104.551% |
| Charles River Laboratories International, Inc. | 2.78 Billion USD | 101.868% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 101.113% |
| Danaher Corporation | 13.67 Billion USD | 100.381% |
| IQVIA Holdings Inc. | 12.85 Billion USD | 100.405% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 100.962% |
| Mettler-Toledo International Inc. | 2.01 Billion USD | 102.591% |
| Qiagen N.V. | 943.04 Million USD | 105.525% |
| Revvity, Inc. | 3.11 Billion USD | 101.671% |
| Thermo Fisher Scientific Inc. | 26.84 Billion USD | 100.194% |
| Waters Corporation | 1.96 Billion USD | 102.658% |